Zentalis Pharmaceuticals, Inc. (ZNTL)
3.76
-0.04
(-1.05%)
USD |
NASDAQ |
Aug 31, 16:00
3.66
-0.10
(-2.66%)
After-Hours: 07:32
Zentalis Pharmaceuticals Cash from Operations (Annual) : -125.25M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -125.25M |
| December 31, 2024 | -170.86M |
| December 31, 2023 | -207.82M |
| December 31, 2022 | -163.75M |
| Date | Value |
|---|---|
| December 31, 2021 | -154.09M |
| December 31, 2020 | -86.82M |
| December 31, 2019 | -39.14M |
| December 31, 2018 | -24.25M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ARS Pharmaceuticals, Inc. | -170.87M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |